Oral mycophenolate mofetil in the treatment of acquired dermal macular hyperpigmentation: An open-label pilot study.
Anuradha BishnoiKeshavamurthy VinayDavinder ParsadSheetanshu KumarDebajyoti ChatterjeeUma Nahar SaikiaMuthu Sendhil KumaranPublished in: The Australasian journal of dermatology (2021)
Mycophenolate mofetil appears to be a promising treatment option in acquired dermal macular hyperpigmentation.